A Double-Blind Trial of Intramuscular Stanozolol in the Prevention of Postoperative Deep Vein Thrombosis Following Elective Abdominal Surgery

Summary Fibrinolytic shutdown may be important in the development of postoperative deep vein thrombosis (DVT). We have previously shown that stanozolol 50 mg, given intramuscularly 24 hr before surgery, prevents the decrease in plasminogen activator activity (PA) seen on the first postoperative day in patients at high risk of DVT. To investigate the role of fibrinolytic shutdown in causation of DVT, sixty patients were randomised in a double-blind controlled trial to receive stanozolol or placebo intramuscularly, and DVT was detected by leg scanning and confirmed by venography. Scan positive DVT occurred in IT of 31 placebo patients (35%) and 12 of 29 who received stanozolol (41%). A significant decrease in PA was confirmed in the placebo group, while stanozolol caused a significant increase in PA on the first postoperative day. Patients in either group who did not develop DVT showed minimal changes in PA. We conclude that prevention of fibrinolytic shutdown by this regimen of stanozolol does not prevent postoperative DVT, and that further studies are required to clarify the relationships of postoperative fibrinolysis and DVT.

[1]  C. Forbes,et al.  Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol. , 1983, Thrombosis research.

[2]  C. Forbes,et al.  The effect of intramuscular stanozolol on fibrinolysis and blood lipids. , 1982, Thrombosis research.

[3]  C. Forbes,et al.  PREDICTION AND SELECTIVE PROPHYLAXIS OF VENOUS THROMBOSIS IN ELECTIVE GASTROINTESTINAL SURGERY , 1982, The Lancet.

[4]  F. Preston,et al.  The Fibrinolytic Response To Stanozolol In Normal Subjects , 1981, Thrombosis and Haemostasis.

[5]  N. Browse,et al.  Changes in the blood fibrinolytic activity after surgery (the effect of deep vein thrombosis and malignant disease) , 1977, The British journal of surgery.

[6]  J A Anderson,et al.  Preoperative prediction of postoperative deep vein thrombosis. , 1976, British medical journal.

[7]  J. A. Hickman,et al.  Postoperative fibrinolytic activity and deep vein thrombosis , 1974, The British journal of surgery.

[8]  J. R. Friend,et al.  Fibrinolytic activity and postoperative deep-vein thrombosis. , 1974, Lancet.

[9]  J. Hirsh,et al.  Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis. , 1973, Lancet.

[10]  J. Calnan,et al.  Ethyloestrenol and postoperative venous thrombosis. , 1973, Lancet.

[11]  A. Mansfield.  Alteration in Fibrinolysis Associated With Surgery and Venous Thrombosis , 1972, The British journal of surgery.

[12]  G. Mcdonald,et al.  Fibrinolytic enhancement by stanozolol: a double-blind trial. , 1972, Journal of clinical pathology.

[13]  D. Negus,et al.  125I‐labelled fibrinogen in the diagnosis of deep‐vein thrombosis and its correlation with phlebography , 1968, The British journal of surgery.